Clinical trial

Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer

NCT05488626

Study summary

ClinicalTrials.gov

Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Adaptive Radiotherapy Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Non-Adaptive Radiotherapy Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Chemotherapy Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Immunotherapy Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2022-10-20

PhaseNA

Conditions

Stage III Non-small Cell Lung Cancerunresolved

Interventions

Adaptive RadiotherapyDEVICE

Non-Adaptive RadiotherapyDEVICE

ChemotherapyDRUG

ImmunotherapyDRUG

Sponsors & collaborators

Varian, a Siemens Healthineers Companylead sponsor

Mapped research locations

BirminghamAlabama, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05488626 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.